Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- The case of Mrs. D
- Case study: CCQ score
- Would you change your management?
- Patient summary
- Treatment options
- GOLD guideline
- Pharmacologic therapy: first choice
- Treatment options SABA; SAMA
- Treatment options LABA; LAMA
- Treatment options ICS
- Hippocratic Oath
- Metabolic effects of ICS in patients with COPD
- Treatment options LABA+LAMA
- Treatment mental state
- Treatment suggestion
- Summary
Topics Covered
- GOLD guideline
- Metabolic effects of COPD treatment
- Case management
- An updated version, which will include the latest GOLD COPD recommendations, will be released in November 2017
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Kocks, J. (2016, February 29). COPD treatment case III: COPD with pre-diabetes [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/TMNS2699.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Janwillem Kocks has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Respiratory Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
Hi.
Welcome to this third case
in the COPD case series.
I'm Janwillem Kocks.
I'm a general practitioner
and an assistant professor
at the Department
of General Practice
at the University Medical Center
in Groningen, the Netherlands.
And this case will be
about a COPD patient
with pre-diabetes.
0:21
So if you've seen the other two,
you will recognize this patient.
This is the same lady,
50 years of age,
works in a community archive,
and she comes to you for
her annual review for COPD.
And she tells you
she has more difficulty,
more breathlessness
the last months in her work
because the carrying
of the boxes with stuff
in the archive
becomes more difficult.
And this lady has
an FEV1 of 74 percent
of predicted,
so mild COPD
and that sounds with
and FEV1/FVC ratio of 68 percent.
And she had a course
of antibiotics
for a lung attack
in the last month
during the out-of-hours service.
She's been smoking
for quite some time
and has a number
of pack years of 35.
And she stopped
smoking four weeks ago.
She's got BMI of 27.8
and a CCQ score of 1.8.
You'll notice that
this is all the same
for all the different cases.
And her medication
is ipratropium,
which she uses about
three times a day
for the last months at least
because of her work.
She uses that when walking
with friends as well.
What's different
compared to the other cases
is that she's got a high
morning glucose level
and she got a diabetic
nurse in your practice
because of this pre-diabetes.
And she gets
advice for her diet,
for her physical activity,
and she's trying
to reduce her weight.